Allele Dmel\Mef2GD5039
| General Information | |||
|---|---|---|---|
| Symbol | Dmel\Mef2GD5039 | Species | D. melanogaster |
| Name | FlyBase ID | FBal0207605 | |
| Feature type | allele | Associated gene | Dmel\Mef2 |
Map (
GBrowse
)
![]() |
| ||
| Allele class | |||
| Mutagen | in vitro construct - RNAi, in vitro construct - regulatory fusion | ||
Recent Updates
|
|||
| Description |
What does this section display?
This section contains items that were added to this record for each release.
It currently only tracks new links between this FlyBase report and other
FlyBase data classes (e.g. genes, references, stocks) or controlled
vocabulary terms (e.g. GO, anatomy terms).
What does this section not display?
This section does not currently display links that were removed or gene model changes.
|
||
| Update Feed |
Click the icon below to subscribe to this FlyBase record and receive updates automatically through your
feed reader.
|
||
| FB2013_03 | |||
| FB2013_02 | |||
| All updates | Click here to see a list of all updates to this record from FB2010_08 and on. | ||
Nature of the Allele
| |||
| Allele class | |||
| Mutagen | |||
| Mutations Mapped to the Genome | |||
Type Location Additional Notes References RNAi reagent | |||
| Associated Sequence Data | |||
| DDBJ
/
EMBL / GenBank | DNA sequence Protein sequence Name | ||
| UniProtKB/Swiss-Prot | |||
| UniProtKB/TrEMBL | |||
| Progenitor genotype | |||
| Nature of the lesion | Statement Reference Scer\UAS regulatory sequences drive expression of an inverted repeat. | ||
| Carried in construct | |||
| Associated Sequence Features | |||
| Cytology | |||
Phenotypic Data
| |||
Phenotypic Class
| |||
Phenotype Manifest In
| |||
Detailed Description
| |||
Statement Reference Animals expressing Mef2[GD5039] under the control of Scer\GAL4[1151] develop normally but remain in their pupal cases and eventually die, unable to eclose. The animals lack essentially all major somatic muscles in their bodies. Cardiac and visceral muscles are unaffected.
In developing pupae expressing Mef2[GD5039] under the control of Scer\GAL4[1151] the development of the indirect flight muscles is severely affected due to a lack of myoblast fusion to form myofibre syncytia. The larval oblique muscles which form the templates for the dorsal longitudinal muscles do not undergo splitting at 24 hours after puparium formation (APF), in contrast to wild type. These templates are smaller than normal in the mutant pupae, whereas the layer of swarming myoblasts surrounding them is significantly thicker than normal. Groups of myoblasts are seen at the putative sites of dorso-ventral muscle formation in the mutant pupae, but they are never accompanied by a fusion core. Fused myofibres are not seen in the thorax of mutant animals at 30 hours APF, but instead large numbers of unfused myoblasts are apparent. At 48 hours APF there is still a lack of fused myotubes, but the number of unfused myoblasts is significantly decreased (they are detected only as small groups of loosely aggregated cells).
The dorsal longitudinal muscles often collapse to the back of the thorax by 48 hours after puparium formation in animals expressing Mef2[GD5039] under the control of Scer\GAL4[Act88F.PB]. The dorso-ventral muscles (DVMs) develop normal looking myofibrils by the end of the pupal stage, although they are somewhat wavy in their organisation. The morphology of the DVM myofibrils is worsened if the animals also carry either Mef2[P544] or Mef2[dsRNA.IR2.Scer\UAS].
Expression of Mef2[GD5039] under the control of Scer\GAL4[Act79B.PB] results in moderate but persistent changes in morphology in the tergal depressor of the trochanter muscle, including the presence of a central cavity within the myofibre rosette, mis-localised and aggregated nuclei and a reduction in overall muscle size. Embryos expressing Mef2[GD5039] under the control of Scer\GAL4[Mef2.PR] show muscle extension and attachment defects. Larvae show a significant reduction in the number of body wall contractions per minute compared to controls. Expression of Mef2[GD5039] under the control of Scer\GAL4[P0.5.Pdf] (in the presence of Dcr-2[Scer\UAS.cDa] to increase RNAi efficiency) causes long locomotor activity rhythms, with a period of 25.0 +/- 0.4 hours. These rhythms have a much lower power than in control flies (32.6 compared to 80.7).
Expression of Mef2[GD5039] under the control of Scer\GAL4[tim.Scer\UAS] (in the presence of Dcr-2[Scer\UAS.cDa] to increase RNAi efficiency) results in 70% of the flies becoming progressively arrhythmic over a 12 day period.
Adult LN[[v]] neurons are present and project normally when Mef2[GD5039] is expressed under the control of Scer\GAL4[tim.Scer\UAS]. Expression under the control of Scer\GAL4[pnr-MD237] results in bristle morphology defects on the notum in 0% or 20-30% of the Scer\GAL4[pnr-MD237] expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4[pnr-MD237] results in the absence of 60-70% or 80-90% of the Scer\GAL4[pnr-MD237]-expressing area of the notum, depending on the insertion line used. Expression of Mef2GD5039 under the control of Scer\GAL4elav.PLu leads to a variable phenotype depending on the insertion, with flies showing variable levels of lethality and some flies showing abnormal wing posture. Scer\GAL4elav.PLu>Mef2GD5039 flies also show flight defects. | |||
External Data
| |||
| Linkouts | Bristle Screen Database
- A database for RNAi phenotypes in bristle and notum development
• | ||
Interactions
| |||
|
|||
Phenotypic Class
| |||
Enhancer of | |||
Statement Reference Mef2GD5039, Scer\GAL4GMR.PFa is an enhancer of visible phenotype of Scer\GAL4GMR.PFa, Zzzz\CTG86.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG | |||
NOT Enhancer of | |||
Statement Reference Mef2GD5039, Scer\GAL4GMR.PFa is a non-enhancer of visible phenotype of Scer\GAL4GMR.PFa, Zzzz\CAG93.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG Mef2GD5039, Scer\GAL4GMR.PFa is a non-enhancer of visible phenotype of Scer\GAL4GMR.PFa, Zzzz\CAGCAA.94.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG | |||
NOT Suppressor of | |||
Statement Reference Mef2GD5039, Scer\GAL4GMR.PFa is a non-suppressor of visible phenotype of Scer\GAL4GMR.PFa, Zzzz\CAG93.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG Mef2GD5039, Scer\GAL4GMR.PFa is a non-suppressor of visible phenotype of Scer\GAL4GMR.PFa, Zzzz\CAGCAA.94.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG | |||
Other | |||
Statement Reference | |||
Phenotype Manifest In
| |||
Enhancer of | |||
Statement Reference Mef2GD5039, Scer\GAL4GMR.PFa is an enhancer of eye phenotype of Scer\GAL4GMR.PFa, Zzzz\CTG86.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG | |||
NOT Enhancer of | |||
Statement Reference Mef2GD5039, Scer\GAL4GMR.PFa is a non-enhancer of eye phenotype of Scer\GAL4GMR.PFa, Zzzz\CAG93.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG Mef2GD5039, Scer\GAL4GMR.PFa is a non-enhancer of eye phenotype of Scer\GAL4GMR.PFa, Zzzz\CAGCAA.94.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG | |||
NOT Suppressor of | |||
Statement Reference Mef2GD5039, Scer\GAL4GMR.PFa is a non-suppressor of eye phenotype of Scer\GAL4GMR.PFa, Zzzz\CAG93.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG Mef2GD5039, Scer\GAL4GMR.PFa is a non-suppressor of eye phenotype of Scer\GAL4GMR.PFa, Zzzz\CAGCAA.94.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG | |||
Other | |||
Statement Reference | |||
Additional Comments
| |||
Genetic Interactions
| |||
Statement Reference | |||
Xenogenetic Interactions
| |||
Statement Reference Co-expression of Mef2[GD5039] with Zzzz\CAG[93.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG] under the control of Scer\GAL4[GMR.PFa] does not alter the appearance of the eye.
Co-expression of Mef2[GD5039] with Zzzz\CAG[CAA.94.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG] under the control of Scer\GAL4[GMR.PFa] does not alter the appearance of the eye.
Co-expression of Mef2[GD5039] with Zzzz\CTG[86.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG] under the control of Scer\GAL4[GMR.PFa] causes an enhancement of the Zzzz\CTG[86.Scer\UAS.T:Hsap\MYC,T:Zzzz\FLAG]-induced eye phenotype, resulting in flies with smaller eyes which have a glazed appearance and necrotic patches.
Co-expression of Mef2[GD5039] with Zzzz\CTG[term.CTG.99.Scer\UAS] under the control of Scer\GAL4[GMR.PFa] results in a marked disruption of the pigmentation and patterning of the eye.
Co-expression of Mef2[GD5039] with Zzzz\CAG[term93.Scer\UAS] under the control of Scer\GAL4[GMR.PFa] does not disrupt eye patterning.
Co-expression of Mef2[GD5039] with Zzzz\CAG[term.CAA.114.Scer\UAS] under the control of Scer\GAL4[GMR.PFa] does not disrupt eye patterning.
Co-expression of Mef2[GD5039] with Hsap\ATXN10[rAUUCU.65.Scer\UAS] under the control of Scer\GAL4[GMR.PFa] does not disrupt eye patterning. | |||
Complementation & Rescue Data
| |||
| Comments | |||
Stocks
( 2 ) | |||
| VDRC | v15550 | ||
Notes on Origin
| |||
| Discoverer | |||
External Crossreferences & Linkouts
| |||
| Other Crossreferences | |||
| Linkouts | |||
Bristle Screen Database
- A database for RNAi phenotypes in bristle and notum development
• | |||
Synonyms & Secondary IDs
( 1 ) | |||
| Reported As | |||
| Symbol Synonym | Mef2GD5039 | ||
| Name Synonym | |||
| Secondary FlyBase IDs | |||
References
( 8 ) | |||
| Research paper |
| ||
| Supplementary material |
| ||
| Personal communication to FlyBase |
| ||

Recent Updates
External Crossreferences & Linkouts